Within the ablation catheters market, Radiofrequency (RF) Ablation held a 67.87% share in 2025, reflecting its entrenched use across established cardiac ablation workflows. its position is underpinned by broad procedural familiarity, deep integration into existing electrophysiology lab practices, and the confidence clinicians place in a modality with long-standing real-world usage. In practical terms, hospitals and specialists tend to favor RF ablation when consistency, operator experience, and installed procedural infrastructure support routine case volumes, which helps preserve its dominant share in the ablation catheters market.

Pulse Field Ablation is emerging as the fastest-growing segment in the ablation catheters market as providers increasingly respond to the need for newer ablation approaches that align with evolving procedural preferences. Its momentum relative to conventional alternatives is being supported by rising clinical interest in technologies that can fit next-generation electrophysiology strategies and encourage adoption in centers looking to expand or modernize their ablation offerings. As the market shifts toward procedural innovation, Pulse Field Ablation is seeing wider adoption because it is closely tied to where new investment, physician attention, and treatment pathway evolution are moving.

End Use Segment Analysis: Inpatient Facilities (Largest Segment) vs Outpatient Facilities (Fastest-Growing Segment)

In 2025, Inpatient Facilities accounted for a 77.62% share of the ablation catheters market, supported by their central role in handling complex ablation procedures that require advanced monitoring, specialized teams, and immediate access to broader hospital resources. Their continued leadership reflects the operational realities of catheter ablation, where many cases still depend on integrated cardiac care settings with established electrophysiology infrastructure. That concentration of expertise, equipment, and post-procedure support keeps inpatient settings at the forefront of demand in the ablation catheters market.

Outpatient Facilities are the fastest-growing end-use segment in the ablation catheters market as care delivery gradually shifts toward settings that can perform appropriate procedures with greater scheduling flexibility and streamlined patient throughput. Their growth is being encouraged by practical demand for more efficient treatment pathways, especially where providers are seeking alternatives to resource-intensive hospital-based care for suitable cases. Compared with inpatient settings, outpatient facilities are gaining momentum because they align with the market’s push toward procedural convenience and more optimized site-of-care utilization.